| Serial Number | 97457119 |
| Word Mark | VIRACTA |
| Filing Date | Tuesday, June 14, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 9, 2024 |
| Registration Number | 7356577 |
| Registration Date | Tuesday, April 9, 2024 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, May 30, 2023 |
| Description of Mark | The mark consists of the stylized word "VIRACTA" with all the elements in teal except for the dot above the "I" which is green. |
| Goods and Services | Pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated cancers and other viral associated diseases and disorders; pharmaceutical products, namely, pharmaceutical products for treating cancer; pharmaceutical products for treating viral infections; pharmaceutical products for immune reconstitution; pharmaceutical products for cell-based immunotherapy; pharmaceutical products for T-cell adoptive transfer; pharmaceutical products for cellular adoptive transfer; pharmaceutical preparations for the treatment of cancer, tumors, and hematological malignancies; all of the foregoing containing antivirals |
| Indication of Colors claimed | The color(s) teal and green is/are claimed as a feature of the mark. |
| Goods and Services | Providing medical information, consultancy and advisory services; providing a website via a global computer network featuring medical information in the fields of cancer, viral-associated cancers and other viral associated diseases and disorders |
| Goods and Services | Development of pharmaceutical preparations and medicines; drug discovery services; pharmaceutical drug development services; research relating to medicines in the nature of pharmaceutical research; medical research; pharmaceutical research and development services; medical research services in the field of cancer, viral-associated cancers and other viral associated diseases and disorders; research and development of biological and chemical preparations for the treatment of cancer, viral-associated cancers and other viral associated diseases and disorders; research and development of pharmaceutical products, preparations and compounds for the treatment of viral-associated cancers and other viral associated diseases and disorders; DNA screening and analysis services for scientific research purposes; research and development of pharmaceutical products, preparations and compounds for T-cell adoptive transfer, immune reconstitution, and cell-based immunotherapy; research and development of pharmaceutical products, preparations and compounds for the treatment of cancer, tumors, and hematological malignancies |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 27, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | Saturday, September 30, 2023 |
| First Use In Commerce Date | Saturday, September 30, 2023 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 27, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, February 24, 2021 |
| First Use In Commerce Date | Wednesday, February 24, 2021 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 27, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | Wednesday, February 24, 2021 |
| First Use In Commerce Date | Wednesday, February 24, 2021 |
| Party Name | Viracta Therapeutics, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cardiff, CA 92007 |
| Party Name | Viracta Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cardiff, CA 92007 |
| Party Name | Viracta Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cardiff, CA 92007 |
| Event Date | Event Description |
| Tuesday, April 9, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, April 9, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, March 6, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, March 5, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Monday, February 5, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, January 16, 2024 | USE AMENDMENT FILED |
| Monday, February 5, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, January 16, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, July 25, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 30, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 30, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 10, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, April 26, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, April 21, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 21, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 3, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 3, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, April 3, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, March 27, 2023 | ASSIGNED TO EXAMINER |
| Monday, June 27, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 17, 2022 | NEW APPLICATION ENTERED |